Peptides Studied in
Cognitive Research
Semax, Selank, Dihexa, and Cerebrolysin represent the most-researched neuropeptide compounds in cognitive function, neuroprotection, and neuroplasticity research. Research-grade, 99%+ purity, batch-specific COA on every order.
What the Research Covers
Neuropeptide cognitive research spans several converging domains: BDNF and neurotrophic factor signaling, dopaminergic and GABAergic neurotransmission, hippocampal synaptogenesis, and mitochondrial neuroprotection. The four compounds on this page represent distinct mechanistic approaches to cognitive and neurological function research, with literature bases ranging from robust preclinical data to published clinical trials in European research institutions.
These research compounds are intended exclusively for in vitro and preclinical laboratory research. They are not approved for therapeutic use and are not intended for human consumption. Researchers should source all compounds with batch-specific COA documentation confirming molecular identity and purity by HPLC and mass spectrometry.
Cognitive Research Compounds
Semax
Semax (ACTH 4-7 Pro-Gly-Pro)
$44.99 / 30mg
Semax is a synthetic ACTH 4-7 analog developed for research on cognitive and neurological function. Preclinical studies have examined its effects on BDNF upregulation, dopaminergic neurotransmission, and attention-related behavior. Clinical research in Russia and Eastern Europe has investigated its application in cerebrovascular conditions and neuroprotection.
Selank
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
$44.99 / 30mg
Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin. Research has examined its anxiolytic properties without sedation or dependence, its modulation of GABAergic and serotonergic systems, and its potential influence on cognitive performance under stress conditions. It combines neuropeptide and immunomodulatory research profiles.
Dihexa
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)
$299.99 / 10mg
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an angiotensin IV analog studied as a potent activator of the HGF/c-Met signaling pathway. Preclinical studies have demonstrated effects on hippocampal neuroplasticity and synaptogenesis that appear to exceed other studied nootropic compounds by several orders of magnitude in direct comparisons.
Cerebrolysin
Cerebrolysin (Neurotrophic Peptide Complex)
$79.99 / 5ml
Cerebrolysin is a standardized neurotrophic peptide preparation containing low-molecular-weight peptides and free amino acids with BDNF-like activity. It has the most extensive clinical research database in the cognitive peptide category, with randomized controlled trials in stroke and vascular dementia, and additional research in Alzheimer's disease models.
Explore the Research
Cognitive Peptide Research: Common Questions
What peptides are most studied for cognitive research?
The most-researched cognitive peptides are Semax, Selank, Dihexa, and Cerebrolysin. Semax is studied for BDNF upregulation and dopaminergic activity. Selank is researched for anxiolytic effects and GABAergic modulation. Dihexa is studied for HGF/c-Met pathway activation and synaptogenesis. Cerebrolysin has the most extensive clinical data, with trials conducted in stroke and Alzheimer's disease research in European settings.
How does Semax differ from Selank in cognitive research?
Semax and Selank are structurally unrelated peptides studied through different mechanisms. Semax is an ACTH 4-7 analog studied for its effects on dopaminergic neurotransmission and BDNF gene expression, with research focusing on attention, learning, and neuroprotection. Selank is a tuftsin analog studied for anxiolytic and immunomodulatory properties, with research focusing on anxiety reduction, GABAergic modulation, and cognitive performance under stress conditions. Some researchers have examined both together for their complementary mechanisms.
What makes Dihexa unique in nootropic peptide research?
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an angiotensin IV analog notable for its activity at the HGF/c-Met receptor system, a pathway with significant roles in hippocampal neuroplasticity and synaptogenesis. Preclinical research has reported cognitive enhancement effects that appear substantially more potent than earlier-studied nootropic compounds in direct comparisons. It represents a newer class of neuropeptide research compounds.
Does Cerebrolysin have clinical research data?
Yes. Cerebrolysin has more clinical research evidence than most peptide compounds in the cognitive category. European clinical trials have studied it in acute ischemic stroke and vascular dementia, with several randomized controlled studies published. Additional research has examined its application in Alzheimer's disease. Its proposed mechanism involves BDNF-like neurotrophic activity and direct neuroprotective effects on neuronal mitochondria.
Are cognitive research peptides structurally similar to naturally occurring neuropeptides?
Several are based on natural structures. Semax is derived from an ACTH fragment. Selank is a synthetic analog of tuftsin, a naturally occurring immunomodulatory peptide. Cerebrolysin contains peptide fragments found in brain tissue. Dihexa is a fully synthetic angiotensin IV analog. Natural origin does not determine research value, as synthetic analogs are often designed for improved stability and receptor selectivity.
What purity standard applies to cognitive research peptides?
All cognitive research peptides should meet at minimum 98% purity by HPLC. At Blackwell BioLabs, Semax, Selank, Dihexa, and Cerebrolysin are all verified at 99%+ purity with mass spectrometry identity confirmation and batch-specific COAs from accredited third-party laboratories.
How should cognitive research peptides be stored?
Semax, Selank, and Dihexa are lyophilized peptides that should be stored away from heat, light, and moisture before reconstitution. Cerebrolysin is supplied as a liquid requiring refrigeration. All four should be stored according to the specifications on their batch-specific Certificates of Analysis. Bacteriostatic water is the standard reconstitution vehicle for lyophilized cognitive peptides.
Is there peer-reviewed clinical research on peptides for cognitive function?
Yes. Cerebrolysin has the strongest clinical trial database, with studies in journals including Stroke and the Journal of Neural Transmission. Selank and Semax have clinical research data primarily from Russian and Eastern European research institutions. Dihexa has robust preclinical data with limited published human trial data as of 2026. All compounds remain subjects of active preclinical and translational investigation.
Ready to Source Research-Grade Compounds?
All products intended exclusively for laboratory research. Not for human consumption. Batch-specific COA included with every order.
All products on this site are intended exclusively for laboratory research and analytical use. They are not intended for human or veterinary use, and are not approved by any regulatory agency for diagnostic, therapeutic, or preventive purposes. Not for human consumption.